INTERNATIONAL PATENT: SANGAMO THERAPEUTICS, INC. FILES APPLICATION FOR "PEPTIDES TARGETING TFRC FOR BLOOD-BRAIN BARRIER CROSSING"

GENEVA, Nov. 19 -- SANGAMO THERAPEUTICS, INC. (501 Canal Blvd.Suite A100Richmond, California 94804) filed a patent application (PCT/US2025/028247) for "PEPTIDES TARGETING TFRC FOR BLOOD-BRAIN BARRIER CROSSING" on May 07, 2025. With publication no. WO/2025/235682, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TIFFANY, Matthew R. (c/o Sangamo Therapeutics, Inc.501 Canal Blvd.Suite A100Richmond, California 94804), OJALA, David S. (c/o Sangamo Therapeutics, Inc.501 Canal Blvd.Suite A100Richmond, California 94804)

Abstract:...